Utilizing Immunosequencing in Cancer Research & Drug Discovery

Adaptive Biotechnologies’ immunoSEQ® Technology is an end-to-end immunosequencing solution capable of profiling millions of B- and T-cell receptors at high throughput and providing a quantitative view into the immune repertoire.

This presentation provides:

    • An overview of the immunoSEQ Technology.
    • Highlighting key use cases of the immunoSEQ Technology in oncology research.
    • Applications in pre-clinical and clinical research settings.
    • An overview of Adaptive’s drug development capabilities, including identifying and characterizing viable therapeutic targets in solid tumors.

immunoSEQ is For Research Use Only. Not for use in diagnostic procedures.

1 - T cells in COVID-19 (Speaker Image) Patrick_Raber_Headshot_150

Patrick Raber, PhD

Sr Manager, Research and Business Development
Adaptive Biotechnologies

Adria Carbo, PhD

Director, Drug Discovery Business Development
Adaptive Biotechnologies

Register for SEQdiscovery

To access this webinar and all other SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.